Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 641 of 5804
-
Could less radiation be enough for HPV throat cancer?
Disease control Recruiting nowThis is a single-arm, observational registry study determining the effects of reduced radiation dose in select patients with human papillomavirus (HPV) positive oropharyngeal cancer.
Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New combo therapy shows promise for tough esophageal cancer
Disease control OngoingThis is an investigator-initiated, single-arm, exploratory clinical study.The study population consisted of non-operative Locally Advanced Esophageal Cancer . The purpose of this study was to evaluate the efficacy and safety of Concurrent Chemoradiotherapy Following Immunotherapy…
Phase: PHASE2 • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Sleep app could stop postpartum depression before it starts
Prevention OngoingThe goal of this clinical trial is to compare two sleep programs in pregnant people with insomnia. The main questions it aims to answer are: 1. What is the efficacy of digital cognitive behavioral therapy for insomnia (CBT-I) versus digital sleep hygiene education (SHE) for prev…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Prevention
Last updated Jun 27, 2026 11:01 UTC
-
Brain zaps and brain games: a new approach to curb veteran suicide
Disease control CompletedImpaired executive function, such as impaired decision making and impulsivity, has been identified as an important contributor to the transition from suicidal ideation to suicide attempt. To address the epidemic of Veteran suicide in the United States, this study tests the feasib…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New vaccine targets KRAS mutation in advanced lung cancer trial
Disease control Recruiting nowThis is a single institution, Phase 1 study for patients with Stage III/IV unresectable Kirsten rat sarcoma (KRAS) mutated NSCLC to evaluate safety of the pooled mutant-KRAS peptide vaccine (KRAS peptide vaccine) with polyinosinic-polycytidylic acid (poly-ICLC) adjuvant in combin…
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New hope for advanced throat cancer: study tests smarter treatment for spread to neck nodes
Disease control Recruiting nowThis is a multi-center, multidisciplinary, open-label, randomized controlled prospective clinical study.
Phase: NA • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Simple drug may stop Post-Surgery brain fog in High-Risk patients
Disease control OngoingProphylactic TxA administration in patients undergoing major gastrointestinal surgery reduces the incidence of delirium after surgery when compared with placebo. The unifying hypothesis is that systemic and neuro-inflammation lead to neuronal injury and resultant postoperative de…
Phase: PHASE3 • Sponsor: Bayside Health • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
AI maps may help surgeons remove more deadly brain tumors
Disease control CompletedGlioblastomas are the most common and poorly prognostic primary brain neoplasms. Despite advances in surgical techniques and chemotherapy, the median survival time for these patients remains less than 15 months. This highlights the need for more effective treatments and improved …
Phase: NA • Sponsor: Hospital del Rio Hortega • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Hope for Alzheimer's agitation: new drug enters final testing
Symptom relief Recruiting nowThis study will be conducted to evaluate the efficacy, safety, tolerability, and pharmacokinetics of masupirdine compared to placebo for the treatment of agitation in participants with dementia of the Alzheimer's type.
Phase: PHASE3 • Sponsor: Suven Life Sciences Limited • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
New hope for Tough-to-Treat blood cancer: MK-1045 enters human trials
Disease control Recruiting nowResearchers are looking for new ways to treat people with a type of blood cancer called precursor B-cell Acute Lymphoblastic Leukemia (B-ALL) that is relapsed- the cancer has come back after treatment, or refractory - the current treatment has stopped working to slow or stop canc…
Phase: PHASE1, PHASE2 • Sponsor: MSD R&D (China) Co., Ltd. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New cocktail of drugs shows promise against tough bile duct cancer
Disease control OngoingThis is a phase II open-label, one-arm, multicenter study aimed to explore the efficacy and safety of perioperative (neoadjuvant and adjuvant) treatment for patients with advanced biliary tract carcinoma.
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could a simple shot replace IV treatments for severe bleeding disorder?
Disease control Recruiting nowVon Willebrand Disease (VWD) is the most common inherited bleeding disorder affecting up to 0.1% of the population, is usually characterized by mucocutaneous bleeding, HMB, surgical bleeding or other hemostatic challenges. Severe bleeding events require VWF concentrates administe…
Phase: PHASE1 • Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Supercharged donor cells aim to stop blood cancer relapse after transplant
Disease control Recruiting nowThis is a multi-center, non-randomized, concurrent controlled, multi-arm, Phase 1 interventional, open-label, biologic assignment-based umbrella study evaluating the feasibility, safety and preliminary efficacy of an escalating dose regimen of up to 2 doses of TSC-100 and TSC-101…
Phase: PHASE1 • Sponsor: TScan Therapeutics, Inc. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New precision approach aims to wipe out breast cancer before surgery
Disease control Recruiting nowThe purpose of this study is to establish a prospective, single-center platform research based on clinical subtypes to explore precision neoadjuvant therapy in patients with operable breast cancer who met the indications for neoadjuvant chemotherapy and by the update of basic tra…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Prepping the body and mind before colon cancer surgery may cut recovery risks
Disease control CompletedONCOFIT is a randomized clinical trial with a two-arm parallel design aimed at determining the influence of a multidisciplinary prehabilitation + postoperative program on post-surgery complications in patients undergoing resection of colon cancer. This intervention will include s…
Phase: NA • Sponsor: Universidad de Granada • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Supercharged immune cells take on tough blood cancers
Disease control Recruiting nowThe goal of this clinical research study is to learn about the safety of giving immune cells called natural killer (NK) cells with chemotherapy to patients with leukemia, lymphoma, or multiple myeloma. Immune system cells (such as NK cells) are made by the body to attack foreign…
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New hope for stage III lung cancer: treatments tailored to your genes
Disease control OngoingThis study will evaluate the efficacy and safety of multiple therapies in participants with locally advanced, unresectable, Stage III NSCLC with eligible biomarker status as determined by Version 8 of the American Joint Committee on Cancer/Union for International Cancer Control (…
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Immune cells harvested from tumors could fight advanced cancers
Disease control Recruiting nowThis is an open label study evaluating lifileucel (LN-144) in patients with metastatic uveal melanoma.
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Tailored timing of radioactive therapy may boost tumor control in NETs
Disease control Recruiting nowThere are several ways of personalizing PRRT (peptide receptor radionuclide treatment) in NEN (neuroendocrine neoplasia). Nevertheless, the current treatment regimen is not personalized. This trial aims to compare personalized PRRT to non-personalized PRRT in terms of safety, eff…
Phase: PHASE3 • Sponsor: Lund University Hospital • Aim: Disease control
Last updated Jun 26, 2026 16:10 UTC
-
Army tests IV antiviral against Kidney-Damaging hemorrhagic fever
Disease control TerminatedMultisite protocol to provide IV Ribavirin treatment to patients with probable or suspected case of Hemorrhagic Fever with Renal Syndrome (HFRS)
Phase: PHASE2 • Sponsor: U.S. Army Medical Research and Development Command • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC